In a significant move to improve cancer prevention and early detection, the National Health Service (NHS) in England has launched a pioneering database of genes linked to cancer. This innovative tool will enable patients and their families to determine their risk of developing the disease, paving the way for personalised and proactive healthcare.
The new NHS National Inherited Cancer Predisposition Register will compile information on 120 genes known to increase the likelihood of cancer, creating a comprehensive resource for healthcare professionals. Patients whose genetic profiles indicate an elevated risk will be offered tailored screening and preventative measures, including routine check-ups for conditions such as breast and prostate cancer.
Health Secretary Wes Streeting hailed the initiative as “life-changing and life-saving,” emphasising its potential to fast-track screening and allow more cancers to be detected at an earlier stage. The register will build upon the success of a similar database for Lynch syndrome, which has already led to over 12,000 people being offered preventative screening.
“One in every two people will get cancer in their lifetime, but that does not mean the chances are random – many people face a higher risk through the genes they inherit,” Streeting explained. “This register won’t just supercharge innovation – it will be life-changing and life-saving, allowing the NHS to develop individual care, fast-track screening and tailored information to enable more cancers to be caught earlier.”
The move has been welcomed by patient advocates, with Claire Rowney, the chief executive of Breast Cancer Now, stating that it will “transform the lives of women who are at increased risk of breast cancer due to their family history or genetics.” Rowney emphasised the importance of ensuring the register is accessible to all clinicians and designed to provide “joined-up care” for those with an elevated risk profile.
The NHS National Inherited Cancer Predisposition Register is a key component of the health service’s 10-year plan to enhance cancer prevention and treatment. Prof Peter Johnson, the NHS England’s national cancer director, described it as “the first time any healthcare system has brought together all the information about all the genetic risk into a single place.”
This groundbreaking initiative promises to revolutionise the way cancer risk is assessed and managed, empowering patients and their families to take proactive steps towards early detection and prevention. As the NHS continues to push the boundaries of personalised healthcare, this database stands as a testament to the organisation’s commitment to delivering innovative, life-saving solutions.